Standards publishers face growing uncertainty as legal shifts and tech disruption challenge traditional subscription models. Monetization is under pressure, prompting a shift toward value-added products that offer integration, usability, and digital delivery to meet evolving user needs.
Standards publishers face growing uncertainty as legal shifts and tech disruption challenge traditional subscription models. Monetization is under pressure, prompting a shift toward value-added products that offer integration, usability, and digital delivery to meet evolving user needs.
In a market where 80% of new products fail, testing and experimentation enable faster decisions, smarter investments, and better odds of success, turning innovation into a disciplined, repeatable growth engine.
This new analysis dives into the $57 billion B2B Media & Business Information market. The segment grew by 8% in 2024, and is back to its normal growth rhythms. Growth opportunities and strong demand for in-person events are overshadowed by geopolitical and economic instability and the threat of AI.
The race to agentic AI is on with mainstream sales, marketing, and support vendors now offering AI agents within existing products and tools. Learn which use cases accelerate insights discovery, streamline customer workflows, and accelerate agentic AI adoption now.
Frictionless search, where users receive insights rather than wading through raw content, has become the benchmark for information platforms. Publishers must strike a balance between the degree of autonomy built into those capabilities and the user’s needs.
Komodo and Nasdaq launch NMCI, merging real-world healthcare data with financial insights. It signals a major shift as healthcare data becomes essential for investors and capital markets strategy.
eLife’s Journal Impact Factor (JIF) eligibility expires next month. Support for the journal indicates the declining importance of the JIF as a standalone metric. This brave new world of transparency amid a multiplicity of metrics opens opportunities and challenges for metrics providers.
D&B’s new move into identity resolution overlays rich business and consumer profiles and signals to create enriched B2B2C profiles. The move puts it in a rarified class of enterprise-level sales and marketing data providers that can do it at this depth and breadth.
CAS and Cleveland Clinic have partnered to accelerate drug discovery in brain health, combining IBM quantum computing capabilities with decades of innovation in scientific data. This alliance reflects CAS’s continued evolution from a trusted content provider to a leading force in healthcare AI.
Global law firm Cleary Gottlieb’s recent acquisition of AI-focused startup Springbok signifies a landmark move when legal services stopped consuming technology and started competing on it.
The customer data platform (CDP) space continues to consolidate as big agencies and enterprise software platforms buy in, niche players specialize, and the middle gets squeezed. Companies evaluating or using CDPs will need to monitor if their tool gets acquired and how things might change.
Siemens’ April 2025 acquisition of Dotmatics marks a decisive leap into the future of life sciences, blending data-driven drug discovery with industrial-scale automation. This move signals a shift toward an integrated, AI-powered ecosystem that is redefining pharmaceutical R&D and manufacturing.
2024 was disappointing to most dealmakers on the M&A front, although an improvement from 2023. While 2025 began with high optimism, economic and trade uncertainty have pushed many to say that happy days may not quite be here again.